NuZee, Inc. - Quarter Report: 2021 December (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended December 31, 2021
or
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ________to________
Commission File No. 001-39338
NUZEE, INC.
(exact name of registrant as specified in its charter)
Nevada | 38-3849791 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
1401 Capital Avenue, Suite B, Plano, TX, 75074
(Address of principal executive offices) (zip code)
(760) 295-2408
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
Common Stock, $0.00001 par value | NUZE | The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated Filer | ☐ | |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of February 4, 2022, the registrant had shares of common stock outstanding.
Table of Contents
2 |
SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS
This report includes “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Such forward-looking statements reflect the views of NuZee, Inc. (“NuZee” or the “Company”) with respect to future events and financial performance. These forward-looking statements are subject to certain uncertainties and other factors that could cause actual results to differ materially from such statements. From time to time, our management or persons acting on our behalf may make forward-looking statements to inform existing and potential security holders about the Company. All statements other than statements of historical facts included in this report regarding our financial position, business strategy, plans and objectives of management for future operations, industry conditions, and indebtedness covenant compliance, or any other matters, are forward-looking statements. When used in this report, forward-looking statements are generally accompanied by terms or phrases such as “estimate,” “expects”, “project,” “predict,” “believe,” “expect,” “anticipate,” “target,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may” or other words and similar expressions that convey the uncertainty of future events or outcomes. Items contemplating or making assumptions about, actual or potential future sales, market size, collaborations, and trends or operating results also constitute such forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Forward-looking statements in this report may include, without limitation, statements regarding:
● | our plans to obtain funding for our operations, including funding necessary to develop, manufacture and commercialize our products and provide our co-packing services; | |
● | the impact to our business from the COVID-19 global crisis, including any supply chain interruptions; | |
● | the evolving coffee preferences of coffee consumers in North America and Korea; | |
● | the size and growth of the markets for our products and co-packing services; | |
● | our ability to compete with companies producing similar products or providing similar co-packing services; | |
● | our expectation that our existing capital resources will be sufficient to fund our operations for at least the next 12 months; | |
● | our expectation regarding our future co-packing revenues; | |
● | our ability to develop innovative new products and expand our co-packing services to other products that are complementary to our current single serve coffee product offerings; | |
● | our reliance on third-party roasters to roast coffee beans necessary to manufacture our products and fulfill every aspect of our co-packing services; | |
● | regulatory developments in the U.S. and in non-U.S. countries; | |
● | our ability to retain key management, sales, and marketing personnel; | |
● | the scope of protection we are able to establish and maintain for intellectual property rights covering our products and technology; | |
● | the accuracy of our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; | |
● | our ability to develop and maintain our corporate infrastructure, including our internal control over financial reporting; | |
● | the outcome of pending, threatened or future litigation; and | |
● | our financial performance. |
The forward-looking statements are not meant to predict or guarantee actual results, performance, events, or circumstances and may not be realized because they are based upon our current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which we have no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Forward-looking statements speak only as of the date they are made. You should consider carefully the statements in the section of our Annual Report on Form 10-K filed with the SEC on December 22, 2021, titled “Risk Factors” and sections of this report that describe factors that could cause our actual results to differ from those set forth in the forward-looking statements.
Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.
3 |
Item 1. Financial Statements.
NuZee, Inc.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
December 31, 2021 | September 30, 2021 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash | $ | 10,967,104 | $ | 10,815,954 | ||||
Accounts receivable, net | 795,301 | 555,238 | ||||||
Inventories, net | 384,198 | 573,464 | ||||||
Prepaid expenses and other current assets | 672,995 | 482,288 | ||||||
Total current assets | 12,819,598 | 12,426,944 | ||||||
Property and equipment, net | 640,322 | 674,024 | ||||||
Other assets: | ||||||||
Right-of-use asset - operating lease | 542,162 | 386,587 | ||||||
Investment | 174,268 | 175,425 | ||||||
Other assets | 79,591 | 79,822 | ||||||
Total other assets | 796,021 | 641,834 | ||||||
Total assets | $ | 14,255,941 | $ | 13,742,802 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 681,531 | $ | 342,790 | ||||
Current portion of long-term loan payable | 31,610 | 43,618 | ||||||
Current portion of lease liability - operating lease | 205,098 | 150,931 | ||||||
Current portion of lease liability - finance lease | 28,729 | 27,833 | ||||||
Accrued expenses | 129,513 | 274,009 | ||||||
Deferred income | 327,219 | 175,822 | ||||||
Other current liabilities | 95,043 | 138,631 | ||||||
Total current liabilities | 1,498,743 | 1,153,634 | ||||||
Non-current liabilities: | ||||||||
Lease liability - operating lease, net of current portion | 348,937 | 247,656 | ||||||
Lease liability - finance lease, net of current portion | 43,830 | 50,567 | ||||||
Loan payable - long term, net of current portion | 10,729 | 12,696 | ||||||
Other noncurrent liabilities | 67,565 | 65,802 | ||||||
471,061 | 376,721 | |||||||
Total liabilities | $ | 1,969,804 | $ | 1,530,355 | ||||
Stockholders’ equity: | ||||||||
Common stock; | shares authorized, $ par value; and shares issued and outstanding as of December 31, 2021, and September 30, 2021, respectively$ | 182 | $ | 178 | ||||
Additional paid in capital | 67,684,455 | 64,839,254 | ||||||
Accumulated deficit | (55,629,011 | ) | (52,824,808 | ) | ||||
Accumulated other comprehensive income | 230,511 | 197,823 | ||||||
Total stockholders’ equity | 12,286,137 | 12,212,447 | ||||||
Total liabilities and stockholders’ equity | $ | 14,255,941 | $ | 13,742,802 |
The accompanying notes are an integral part of these unaudited consolidated financial statements
4 |
NuZee, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
Three Months Ended December 31, 2021 | Three Months Ended December 31, 2020 | |||||||
Revenues, net | $ | 1,019,253 | $ | 517,987 | ||||
Cost of sales | 1,003,882 | 516,284 | ||||||
Gross profit | 15,371 | 1,703 | ||||||
Operating expenses | 2,852,793 | 5,903,826 | ||||||
Loss from operations | (2,837,422 | ) | (5,902,123 | ) | ||||
Loss from investment in unconsolidated affiliate | (1,157 | ) | (2,056 | ) | ||||
Other income | 42,757 | 12,621 | ||||||
Interest income | 245 | 94 | ||||||
Other expense | (5,818 | ) | (569 | ) | ||||
Interest expense | (2,808 | ) | (4,039 | ) | ||||
Net loss | $ | (2,804,203 | ) | $ | (5,896,072 | ) | ||
Basic and diluted loss per common share | $ | (0.16 | ) | $ | (0.40 | ) | ||
Basic and diluted weighted average number of common stock outstanding | 18,011,292 | 14,741,974 |
The accompanying notes are an integral part of these unaudited consolidated financial statements
5 |
NuZee, Inc.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(UNAUDITED)
NuZee, Inc. | ||||||||
For the three months ended December 31 | 2021 | 2020 | ||||||
Net loss | $ | (2,804,203 | ) | $ | (5,896,072 | ) | ||
Foreign currency translation | 32,688 | 1,656 | ||||||
Total other comprehensive income, net of tax | 32,688 | 1,656 | ||||||
Comprehensive loss | $ | (2,771,515 | ) | $ | (5,894,416 | ) |
The accompanying notes are an integral part of these unaudited consolidated financial statements
6 |
NuZee, Inc.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(UNAUDITED)
Accumulated | ||||||||||||||||||||||||
Additional | other | |||||||||||||||||||||||
Common stock | paid-in | Accumulated | comprehensive | |||||||||||||||||||||
Shares | Amount | capital | deficit | income | Total | |||||||||||||||||||
Balance September 30, 2021 | 17,820,390 | $ | 178 | $ | 64,839,254 | $ | (52,824,808 | ) | $ | 197,823 | $ | 12,212,447 | ||||||||||||
Exercise of warrants | 384,447 | 4 | 1,721,014 | - | - | 1,721,018 | ||||||||||||||||||
Stock option expense | - | - | 1,124,187 | - | - | 1,124,187 | ||||||||||||||||||
Other comprehensive gain | - | - | - | - | 32,688 | 32,688 | ||||||||||||||||||
Net loss | - | - | - | (2,804,203 | ) | - | (2,804,203 | ) | ||||||||||||||||
Balance December 31, 2021 | 18,204,837 | $ | 182 | $ | 67,684,455 | $ | (55,629,011 | ) | $ | 230,511 | $ | 12,286,137 |
Accumulated | ||||||||||||||||||||||||
Additional | other | |||||||||||||||||||||||
Common stock | paid-in | Accumulated | comprehensive | |||||||||||||||||||||
Shares | Amount | capital | deficit | income | Total | |||||||||||||||||||
Balance September 30, 2020 | 14,570,105 | $ | 146 | $ | 40,472,229 | $ | (34,272,778 | ) | $ | 190,161 | $ | 6,389,758 | ||||||||||||
- | ||||||||||||||||||||||||
Equity securities issued for cash | 324,959 | 3 | 2,683,977 | - | - | 2,683,980 | ||||||||||||||||||
Stock option expense | - | - | 4,507,298 | - | - | 4,507,298 | ||||||||||||||||||
Exercise of stock options | 6,000 | - | 9,180 | - | - | 9,180 | ||||||||||||||||||
Other comprehensive gain | - | - | - | - | 1,656 | 1,656 | ||||||||||||||||||
Net loss | - | - | - | (5,896,072 | ) | (5,896,072 | ) | |||||||||||||||||
Balance December 31, 2020 | 14,901,064 | $ | 149 | $ | 47,672,684 | $ | (40,168,850 | ) | $ | 191,817 | $ | 7,695,800 |
The accompanying notes are an integral part of these unaudited consolidated financial statements.
7 |
NuZee, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Three Months Ended | Three Months Ended | |||||||
December 31, 2021 | December 31, 2020 | |||||||
Operating activities: | ||||||||
Net loss | $ | (2,804,203 | ) | $ | (5,896,072 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and Amortization | 36,711 | 121,824 | ||||||
Noncash lease expense | 36,822 | 70,933 | ||||||
Stock option expense | 1,124,187 | 4,507,298 | ||||||
Sales allowance | - | 2,018 | ||||||
Loss from investment in unconsolidated affiliate | 1,157 | 2,056 | ||||||
Change in operating assets and liabilities: | ||||||||
Accounts receivable | (240,063 | ) | (27,012 | ) | ||||
Inventories | 189,266 | (10,928 | ) | |||||
Prepaid expenses and other current assets | 66,527 | (186,466 | ) | |||||
Other assets | 231 | (906 | ) | |||||
Accounts payable | 81,507 | (27,012 | ) | |||||
Deferred income | 151,397 | (23,125 | ) | |||||
Lease liability – operating lease | (36,949 | ) | (63,507 | ) | ||||
Accrued expenses and other current liabilities | (188,084 | ) | (169,784 | ) | ||||
Other non-current liabilities | 1,763 | 1,610 | ||||||
Net cash used in operating activities | (1,579,731 | ) | (1,699,073 | ) | ||||
Investing activities: | ||||||||
Purchase of equipment | (3,009 | ) | (58,990 | ) | ||||
Net cash used in investing activities | (3,009 | ) | (58,990 | ) | ||||
Financing activities: | ||||||||
Proceeds from exercise of options | - | 9,180 | ||||||
Repayment of loans | (13,975 | ) | (8,594 | ) | ||||
Repayment of finance lease | (5,841 | ) | (5,146 | ) | ||||
Proceeds from exercise of warrants, net of issuance costs | 1,721,018 | - | ||||||
Proceeds from issuance of equity securities, net of issuance costs | - | 2,683,980 | ||||||
Net cash provided by financing activities | 1,701,202 | 2,679,420 | ||||||
Effect of foreign exchange on cash | 32,688 | 1,656 | ||||||
Net change in cash | 151,150 | 923,013 | ||||||
Cash, beginning of period | 10,815,954 | 4,398,545 | ||||||
Cash, end of period | $ | 10,967,104 | $ | 5,321,558 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid for interest | $ | 2,808 | $ | 4,039 | ||||
Cash paid for taxes | $ | $ | 250 | |||||
Non-cash transactions: | ||||||||
Deferred offering costs accrued | $ | 257,234 | $ | 213,857 | ||||
ROU assets and liabilities added during the period | $ | 192,397 | $ |
The accompanying notes are an integral part of these unaudited consolidated financial statements
8 |
NuZee, Inc.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
December 31, 2021
1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited interim consolidated financial statements of NuZee, Inc. (together with its subsidiaries, referred to herein as the “Company”, “we” or “NuZee”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and rules of the Securities and Exchange Commission (the “SEC”), and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended September 30, 2021 as filed with the SEC on December 22, 2021. In the opinion of management, all adjustments, consisting of recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements as reported in the Annual Report on Form 10-K for the year ended September 30, 2021 have been omitted.
Reclassification
Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net loss.
Principles of Consolidation
The Company prepares its financial statements on the accrual basis of accounting. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts, balances and transactions have been eliminated upon consolidation.
The Company has two wholly owned international subsidiaries in NuZee KOREA Ltd. (“NuZee KR”) and NuZee Investment Co., Ltd. (“NuZee INV”).
Basic earnings per common share is equal to net earnings or loss divided by the weighted average of shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options, warrants and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. As of December 31, 2021 and December 31, 2020, the total number of common stock equivalents was and , respectively, comprised of stock options and warrants as of December 31, 2021 and December 30, 2020. The Company incurred a net loss for the three months ended December 31, 2021 and 2020, respectively, and therefore basic and diluted earnings per share for those periods are the same because all potential common equivalent shares would be antidilutive.
Capital Resources
Since its inception, the Company has devoted substantially all its efforts to business planning, research and development, recruiting management and technical staff, acquiring operating assets, raising capital, and the commercialization and manufacture of its single serve coffee products. The Company has generated limited revenues from its principal operations, and there is no assurance of future revenues.
9 |
As of December 31, 2021, the Company had cash of $10,967,104. However, the Company has not attained profitable operations since inception.
Major Customers
In the three months ended December 31, 2021 and 2020, revenue was primarily derived from major customers disclosed below.
Three months ended December 31, 2021:
Customer Name | Sales Amount | % of Total Revenue | Accounts Receivable Amount | % of Total Accounts Receivable | ||||||||||||
Customer WP | $ | 310,551 | 30 | % | $ | 279,273 | 35 | % | ||||||||
Customer CU | $ | 199,936 | 20 | % | $ | 137,566 | 17 | % |
Three months ended December 31, 2020:
Customer Name | Sales Amount | % of Total Revenue | Accounts Receivable Amount | % of Total Accounts Receivable | ||||||||||||
Customer WP | $ | 156,299 | 30 | % | $ | 94,066 | 43 | % | ||||||||
Customer RSM | $ | 66,811 | 13 | % | $ | 0 | % | |||||||||
Customer GR | $ | 65,536 | 13 | % | $ | 65,352 | 30 | % |
Lease
In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), to provide guidance on recognizing lease assets and lease liabilities on the consolidated balance sheet and disclosing key information about leasing arrangements, specifically differentiating between different types of leases. The Company implemented ASU No. 2016-02 on October 1, 2019.
The Company performs a quarterly analysis of leases to determine if there are any operating leases that require recognition under ASC 842. The Company has one significant long-term operating lease for office and manufacturing space in Plano, Texas. The leased property in Plano, Texas, has a remaining lease term through June 2024. The lease has an option to extend beyond the stated termination date, but exercise of this option is not probable. The Company did not apply the recognition requirements of ASC 842 to operating leases with a remaining lease term of 12 months or less.
During our analysis of leases in the three months ended December 31, 2021, we determined to renew the office and manufacturing space in Vista, California which was originally scheduled to expire on January 31, 2022, for an additional year through January 31, 2023. The lease has a monthly lease expense of $8,451, plus common area expenses. We extended our sub-leased property in Vista, California, through January 31, 2023, which has been calculated as a ROU Asset co-terminus with the direct-leased property. The Seoul, Korea office and manufacturing space lease was extended through June 2022 and there is an apartment leased through June 2022. Additionally, the Company leased a new larger office and manufacturing space in Seoul, Korea beginning November 15, 2021, through November 15, 2023. The lease has a monthly expense of $7,040. Accordingly, we have added ROU assets and lease liabilities related to those leases at December 31, 2021.
10 |
As of December 31, 2021, our operating leases had a weighted average remaining lease term of 1.7 years and a weighted-average discount rate of 5%. Other information related to our operating leases is as follows:
ROU Asset – October 1, 2021 | $ | 386,587 | ||
ROU Asset added during the period | 192,397 | |||
Amortization during the period | (36,822 | ) | ||
ROU Asset –December 31, 2021 | $ | 542,162 | ||
Lease Liability – October 1, 2021 | $ | 398,587 | ||
Lease Liability added during the period | 192,397 | |||
Amortization during the period | (36,949 | ) | ||
Lease Liability – December 31, 2021 | $ | 554,035 |
Lease Liability – Short-Term | $ | 205,098 | ||
Lease Liability – Long-Term | 348,937 | |||
Lease Liability – Total | $ | 554,035 |
The table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining years to the lease liabilities recorded on the Consolidated Balance Sheet as of December 31, 2021:
Amounts due within 12 months of December 31,
2022 | $ | 335,586 | ||
2023 | 220,913 | |||
2024 | 64,936 | |||
2025 | ||||
2026 | ||||
Total Minimum Lease Payments | 621,435 | |||
Less Effect of Discounting | (67,400 | ) | ||
Present Value of Future Minimum Lease Payments | 554,035 | |||
Less Current Portion of Operating Lease Obligations | 205,098 | |||
Long-Term Operating Lease Obligations | $ | 348,937 |
On October 9, 2019, the Company entered into a lease agreement with Alliance Funding Group which provided for a sale lease back on certain packing equipment. The terms of this agreement require us to pay $2,987 per month through July 2024. As part of this agreement, Alliance Funding Group provided our equipment supplier with $124,500 for the purchase of this equipment. This transaction was accounted for as a financing lease. As of December 31, 2021, our financing lease had a remaining lease term of 2.5 years and a discount rate of 12.75%. The interest expense on finance lease liabilities for the three months ended December 31, 2021 was $2,437.
During the year ended September 30, 2021, we recorded an impairment to fully write off the related equipment as it was deemed no longer useful for our operations.
The table below summarizes future minimum finance lease payments at December 31, 2021 for the 12 months ended December 31:
2022 | $ | 33,113 | ||
2023 | 33,113 | |||
2024 | 19,316 | |||
2025 | ||||
2026 | ||||
Total Minimum Lease Payments | 85,542 | |||
Amount representing interest | (12,983 | ) | ||
Present Value of Minimum Lease Payments | 72,559 | |||
Current Portion of Finance Lease Obligations | 28,729 | |||
Finance Lease Obligations, Less Current Portion | $ | 43,830 |
Rent expense included in general and administrative expense for the three months ended December 31, 2021 and 2020 was $90,525 and $93,750, respectively.
11 |
Cash and non-cash activities associated with the leases for the three months ended December 31, 2021 are as follows:
Operating cash outflows from operating leases: | $ | 36,949 | ||
Operating cash outflows from finance lease: | $ | 2,437 | ||
Financing cash outflows from finance lease: | $ | 5,841 |
In September 2020, we subleased the space at 1700 Capital Avenue in Plano, Texas, effective October 1, 2020, under favorable terms that are co-terminus with the original lease ending June 30, 2024. During the three months ended December 31, 2021, we recognized sublease income of $42,757 pursuant to the sublease included in Other income on our financial statements. Future minimum lease payments to be received under that sublease as of December 31, 2021, for each of the twelve months ended December 31 are as follows:
2022 | $ | 124,190 | ||
2023 | 127,926 | |||
2024 | 64,918 | |||
2025 | ||||
2026 | ||||
Total | $ | 317,034 |
Loans
On April 1, 2019, we purchased a delivery van from Ford Motor Credit for $41,627. The Company paid $3,500 as a down payment and financed $38,127 for 60 months at a rate of 2.9%. The loan is secured by the van. The outstanding balance on the loan at December 31, 2021 and September 30, 2021 amounted to $18,506 and $20,416, respectively.
On February 15, 2019, NuZee KR entered into equipment financing for production equipment with Shin Han Bank for $60,563. In June 2019, NuZee KR purchased additional equipment and increased the loan with Shin Han Bank by $86,518. The financing has a term of 36 months at a rate of 4.33%. Principal payments began in July 2019. The outstanding balance on this loan at December 31, 2021 and September 30, 2021 amounted to $23,833 and $35,898, respectively.
The remaining loan payments are as follows:
Ford Motor Credit | ShinHan Bank | Total | ||||||||||
2022 (Jan 2022 - Sep 2022) | $ | 5,812 | $ | 13,248 | $ | 19,060 | ||||||
2023 (Oct 2022 - Dec 2022) | 1,965 | 10,585 | 12,550 | |||||||||
Total Current Portion | $ | 7,777 | $ | 23,833 | $ | 31,610 | ||||||
2023 (Jan 2023 - Sep 2023) | $ | 8,005 | $ | 8,005 | ||||||||
2024 | 2,724 | 2,724 | ||||||||||
Total Long-Term Portion | $ | 10,729 | $ | $ | 10,729 | |||||||
Grand Total | $ | 18,506 | $ | 23,833 | $ | 42,339 |
Revenue Recognition
In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (Topic 606) “Revenue from Contracts with Customers.” Topic 606 supersedes the revenue recognition requirements in Topic 605 “Revenue Recognition” (Topic 605). The new standard’s core principle is that an entity will recognize revenue at an amount that reflects the consideration to which the entity expects to be entitled in exchange for transferring goods or services to a customer. The principles in the standard are applied in five steps: 1) Identify the contract(s) with a customer; 2) Identify the performance obligations in the contract; 3) Determine the transaction price; 4) Allocate the transaction price to the performance obligations in the contract; and 5) Recognize revenue when (or as) the entity satisfies a performance obligation. We adopted Topic 606 as of October 1, 2018, on a modified retrospective basis. The adoption of Topic 606 did not have a material impact on our consolidated financial statements, including the presentation of revenues in our Consolidated Statements of Operations.
12 |
Foreign Currency Translation
The financial position and results of operations of each of the Company’s foreign subsidiaries are measured using the foreign subsidiary’s local currency as the functional currency. Revenues and expenses of each such subsidiary have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities have been translated at the rates of exchange on the balance sheet date. The resulting translation gain and loss adjustments are recorded directly as a separate component of stockholders’ equity unless there is a sale or complete liquidation of the underlying foreign investment. Foreign currency translation adjustments recorded to other comprehensive gain amounted to $32,688 and $1,656 for the three months ended December 31, 2021 and 2020, respectively.
Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the results of operations as incurred.
Inventories
Inventory, consisting principally of raw materials, work in process and finished goods held for production and sale, is stated at the lower of cost or net realizable value, cost being determined using the weighted average cost method. The Company reviews inventory levels at least quarterly and records a valuation allowance when appropriate. At December 31, 2021 and September 30, 2021, the carrying value of inventory was $384,198 and $573,464, respectively.
December 31, 2021 | September 30, 2021 | |||||||
Raw materials | $ | 366,639 | $ | 552,621 | ||||
Finished goods | 17,559 | 20,843 | ||||||
Less – Inventory reserve | - | - | ||||||
Total | $ | 384,198 | $ | 573,464 |
Joint Venture
On January 9, 2020, a joint venture agreement was signed between Industrial Marino, S.A. de C.V. (50%) and the Company (50%) forming NuZee LATIN AMERICA (NLA), S.A. de C.V. NLA was formed pursuant to the laws of Mexico, with corporate domicile in Mazatlan, Mexico. As part of the capitalization of NLA, the Company contributed two co-packing machines to the joint venture. These machines had an aggregate carrying cost of $313,012. The Company received $110,000 in cash for this contribution and recorded an investment in NLA of $160,000 and a loss of $43,012 on the contribution of the machines to NLA.
The Company accounts for NLA using the equity method of accounting since the management of day-to-day operations at NLA ultimately lies with the Company’s joint venture partner as the operations of NLA are based in its partners facilities and our partner appoints the Chairman of the joint board of directors of NLA. As of December 31, 2021, the only activity in NLA was the contribution of two machines as described above and other start up related activities. $1,157 of a loss and $2,056 of a loss was recognized under the equity method of accounting during the three months ended December 31, 2021, and December 31, 2020 respectively.
2. GEOGRAPHIC CONCENTRATION
The Company is organized based on fundamentally one business segment although it does sell its products on a world-wide basis. The Company is organized in three geographical segments. The Company co-packs product for customers and produces and sells its products directly in North America and Korea. The Company has a minimally staffed office in Japan that provides support for import and export of product and materials between the U.S. and Japan, as well as investor relations support to our shareholders based in Japan. Information about the Company’s geographic operations for the three months ended December 31, 2021 and 2020 are as follows:
13 |
Geographic Concentrations
Three Months Ended | Three Months Ended | |||||||
December 31, 2021 | December 30, 2020 | |||||||
Net Revenue: | ||||||||
North America | $ | 817,341 | $ | 406,488 | ||||
South Korea | 201,912 | 111,499 | ||||||
$ | 1,019,253 | $ | 517,987 |
Property and equipment, net: | As of December 31, 2021 | As of September 30, 2021 | ||||||
North America | $ | 462,389 | $ | 517,966 | ||||
South Korea | 176,810 | 154,562 | ||||||
Japan | 1,123 | 1,496 | ||||||
$ | 640,322 | $ | 674,024 |
3. RELATED PARTY TRANSACTIONS
For the three months ended December 31, 2021 and December 31, 2020, respectively, the Company had sales of $0 and $15,998 of materials to NLA.
4. ISSUANCE OF EQUITY SECURITIES
Exercise of Warrants
In the three months ended December 31, 2021, we issued 380,447 Series A Warrants and shares of common stock issued upon exercise of 8,000 Series B Warrants. In connection with such exercises, in the three months ended December 31, 2021, we received aggregate net proceeds of $1,721,018.
shares of common stock related to exercises of warrants, including shares of common stock issued upon exercise of
ATM Offering
On December 28, 2021, we entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with Maxim Group LLC, as agent (the “Agent”), pursuant to which we may offer and sell, from time to time, shares of our common stock through the Agent in “at-the-market-offerings”, as defined in Rule 415 under the Securities Act, having an aggregate offering price of up to $20,000,000, subject to any applicable limits when using Form S-3 (the “ATM Offering”). Pursuant to the Equity Distribution Agreement, we will pay the Agent a commission rate, in cash, equal to 3.0% of the aggregate gross proceeds from each sale of shares of our common stock under the Equity Distribution Agreement. The offer and sale of shares of our common stock will be made pursuant to a shelf registration statement on Form S-3 and the related prospectus (File No. 333-248531) initially filed by us with the SEC on September 1, 2020, and declared effective by the SEC on October 2, 2020, under the Securities Act. We are not obligated to make any sales of shares of our common stock under the Equity Distribution Agreement. As of December 31, 2021, no sales had occurred under the Equity Distribution Agreement. For information regarding sales made under the Equity Distribution Agreement following the quarter ended December 31, 2021, see Note 6—Subsequent Events.
Options
During the three months ended December 31, 2021, the Company granted no new stock options, had of stock options that were forfeited because of the termination of employment, and issued no shares upon the exercise of outstanding stock options.
14 |
Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (years) | Aggregate Intrinsic Value | |||||||||||||
Outstanding at September 30, 2021 | 4,511,691 | $ | 4.73 | $ | 452,206 | |||||||||||
Granted | ||||||||||||||||
Exercised | ||||||||||||||||
Expired | ||||||||||||||||
Forfeited | (192,666 | ) | 14.11 | |||||||||||||
Outstanding at December 31, 2021 | 4,319,025 | $ | 4.31 | $ | 4,320,497 | |||||||||||
Exercisable at December 31, 2021 | 1,704,638 | $ | 4.82 | $ | 1,953,581 |
The Company is expensing these stock option awards on a straight-line basis over the requisite service period. The Company recognized stock option expense of $1,124,187 for the three months ended December 31, 2021. Unamortized option expense as of December 31, 2021 for all options outstanding amounted to $3,603,243. These costs are expected to be recognized over a weighted average period of years. The Company recognized stock option expense of $4,507,298 for the three months ended December 31, 2020.
Nonvested options
Number of Nonvested Options | Weighted Average Grant Date Fair Value | |||||||
Nonvested options at September 30, 2021 | 2,870,799 | $ | 5.02 | |||||
Granted | ||||||||
Forfeited | (26,000 | ) | 2.60 | |||||
Vested | (230,412 | ) | 6.09 | |||||
Nonvested options at December 31, 2021 | 2,614,387 | $ | 4.95 |
Warrants
On June 23, 2020, as part of our agreement with Benchmark Company, LLC, the underwriter of the Company’s June 2020 registered public offering of common stock, we issued 40,250 warrants to purchase our common stock at an exercise price of $9.00 a share. These warrants are exercisable on December 23, 2020 and expire on June 18, 2025.
On March 19, 2021, we entered into an underwriting agreement in connection with our registered public offering (the “Offering”) of (i) 4.50 per Unit, with each Unit consisting of (a) one share of our common stock, (b) one Series A Warrant, and (c) one Series B Warrant (together with the Series A Warrants, the “Warrants”), and (ii) 416,666 Series A Warrants and 416,666 Series B Warrants, each pursuant to the underwriter’s full exercise of their overallotment option with respect to such warrants. units (the “Units”), at a price to the public of $
Each Series A Warrant entitles the registered holder to purchase one share of our common stock at an exercise price of $4.50 per share. Each Series B Warrant entitles the registered holder thereof to purchase one-half of a share of our common stock at an exercise price of $5.85 per whole share. These warrants have a term of 5 years.
15 |
The Series A and Series B Warrant holders are obligated to pay the exercise price in cash upon exercise of the Warrants unless we fail to maintain a current prospectus relating to the common stock issuable upon the exercise of the Warrants (in which case, the Warrants may only be exercised via a “cashless” exercise provision).
The following table summarizes warrant activity for the three months ended December 31, 2021:
Number of Shares Issuable Upon Exercise of Warrants | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (years) | Aggregate Intrinsic Value | |||||||||||||
Outstanding at September 30, 2021 | 4,831,915 | $ | 4.98 | $ | ||||||||||||
Issued | ||||||||||||||||
Exercised | (384,447 | ) | 4.51 | |||||||||||||
Expired | ||||||||||||||||
Outstanding at December 31, 2021 | 4,447,468 | $ | 5.02 | |||||||||||||
Exercisable at December 31, 2021 | 4,447,468 | $ | 5.02 | $ |
In the three months ended December 31, 2021, we issued 380,447 Series A Warrants and shares of common stock issued upon exercise of 8,000 Series B Warrants. In connection with such exercises, in the three months ended December 31, 2021, we received aggregate net proceeds of $1,721,018.
shares of common stock related to exercises of warrants, including shares of common stock issued upon exercise of
6. SUBSEQUENT EVENTS
ATM Offering—Sales under Equity Distribution Agreement
During the period from January 1, 2022 through February 4, 2022, we issued and sold 12,542. In connection with such sales, we paid compensation to the Agent in the amount of $ . See Note 4—Issuance of Equity Securities for additional information related to the Equity Distribution Agreement and the ATM Offering. shares of our common stock under the Equity Distribution Agreement, raising net proceeds of $
Agreement with Farmer Bros. Co.
As previously disclosed in 2020, we entered into an Equipment Bailment and Contract Manufacturing Agreement (the “FBC Agreement”) with Farmer Bros. Co. (“FBC”), pursuant to which FBC agreed to provide us with access to manufacturing capacity and was obligated to manufacture finished products for us. On January 27, 2022, we and FBC mutually agreed to terminate the FBC Agreement, effective immediately. Prior to its termination, the Company had placed one machine with FBC under the FBC Agreement. The Company plans to pick up the machine within 60 days of the termination date and redeploy the machine to one of its two manufacturing locations in the United States.
Director Compensation Policy
On January 11, 2022, the Company’s Board of Directors (the “Board”) adopted and approved a new director compensation policy pursuant to which the Company will provide the following compensation to its non-employee Board members: (i) annual cash compensation of $10,000, $7,500 and $5,000, respectively. , effective as of October 1, 2021 and payable quarterly in advance; (ii) payment to each Board member of reasonable out-of-pocket expenses for travel costs to attend Board meetings; (iii) beginning with the Company’s 2022 Annual Meeting of Stockholders, pursuant to the NuZee, Inc. 2019 Stock Incentive Plan, annual grants of restricted shares of common stock with an aggregate grant date fair value of $ to each Board member upon such Board member’s election or re-election, as applicable, to the Board at each annual meeting of stockholders, and (iv) annual payments to the Audit Committee Chair, Compensation Committee Chair and Nominating and Corporate Governance Committee Chair of $
Amended Non-Binding Letter of Intent for Potential Asset Acquisition; Bridge Loan
As previously disclosed in the Company’s Current Report on Form 8-K filed on December 29, 2021, the Company announced it entered into a non-binding letter of intent (the “Letter of Intent”) affording the Company an exclusivity period lasting until January 31, 2022, to negotiate a definitive agreement (the “Definitive Agreement”) to acquire substantially all the assets (the “Potential Transaction”) of an unaffiliated, privately held company in the coffee industry (the “Third Party”). On February 3, 2022, the Company and the Third Party amended the Letter of Intent to extend the exclusivity period to March 1, 2022 (the “Extension”). In consideration of the Extension, the Company agreed to loan the Third Party up to $35,000 in the aggregate in two tranches, as follows: (i) $ was loaned to the Third Party on February 3, 2022 and is intended to provide the Third Party with operational financing while the parties continue negotiations to enter into a Definitive Agreement; and (ii) $ is expected to be loaned to the Third Party, if at all, in the event that a Definitive Agreement is entered into between the parties, which is expected to be an advance on the purchase price set forth in the Definitive Agreement and is intended to provide the Third Party with operational financing as the parties work to close the Potential Transaction following signing of the Definitive Agreement. Upon closing of the Potential Transaction (if any), the first tranche of $13,000 is expected to be designated as an assumed liability under the Definitive Agreement for the benefit of the Third Party and the second tranche of $22,000 is expected to be offset and reduce the purchase price to be paid by the Company. Except in certain limited circumstances, the amounts loaned are expected to become due and payable on the later of the closing of the Potential Transaction (if any) and March 31, 2022. The amounts loaned will accrue interest at the rate of 1% per annum, subject to increase upon certain events of default.
16 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Overview
We are a specialty coffee company and, we believe, a leading co-packer of single serve pour over coffee in the United States, as well as a preeminent co-packer of tea-bag style coffee. Our mission is to leverage our position as a co-packer at the forefront of the North American single serve coffee market to revolutionize the way single serve coffee is enjoyed in the United States. While the United States is our core market, we also have manufacturing and sales operations in Korea and a joint venture in Latin America.
We believe we are the only commercial-scale producer that has the dual capacity to pack both single serve pour over coffee and tea-bag style coffee within the North American market. We intend to leverage our position to be the commercial manufacturer of choice for major companies seeking to enter the single serve pour over and tea-bag style coffee markets in North America. We target existing high-margin companies and are paid per-package based on the number of single serve coffee products produced by us. Accordingly, we consider our business model to be a form of tolling arrangement, as we receive a fee for almost every single serve coffee product our co-packing customers sell in the North American and Korean markets. While we financially benefit from the success of our co-packing customers through the sales of their respective single serve pour over and tea-bag style coffee products, we are also able to avoid the risks associated with owning and managing the product and its related inventory.
We have also developed and sell NuZee branded single serve coffee products, including our flagship Coffee Blenders line of both single serve pour over coffee and tea-bag style coffee, which we believe offers consumers some of the best coffee available in a single serve application in the world.
We may also consider co-packaging other products that are complementary to our current product offerings and provide us with a deeper access to our customers. In addition, we are continually exploring potential strategic partnerships, co-ventures, and mergers, acquisitions, or other transactions with existing and future business partners to generate additional business, reduce manufacturing costs, expand into new markets, and further penetrate the markets in which we currently operate.
Since 2016, we have been primarily focused on single serve pour over coffee production. Over this time, we have developed expertise in the operation of our sophisticated packing equipment and the related production of our single serve pour over coffee products at both our Vista, California facility and at our production operations in Seoul, Korea. In addition, our manufacturing facility and corporate headquarters in Plano, Texas is now operational. We have also expanded our co-packing expertise to tea bag style coffee products, which we believe are gaining traction in the United States.
Impact of the COVID-19 Pandemic
The ongoing COVID-19 global and national health emergency has caused significant disruption in the international and United States economies and financial markets. In the three months ended December 31, 2021, as a result of the COVID-19 pandemic and responses to the outbreak, certain of our customers slowed or delayed purchases of our co-packing services or single serve coffee products, and we also believe that potential sales of our single serve coffee products to new or potential customers in the hospitality industry were adversely impacted. We have also experienced delays in the submission and approval of custom artwork and packaging as well as the shipment to us of coffee for co-packing. In addition, we incurred lost production time due to employee absences. We do not believe, however, that these delays and disruptions had a significant effect on our business or results of operations to date, and in some cases, we have been able to mitigate these adverse effects in part by sourcing coffee and other supplies from alternative suppliers in the United States. The COVID-19 crisis may have an adverse impact on our business and financial results going forward that we are not currently able to fully determine or quantify. The COVID-19 crisis may adversely affect the ability of our customers to pay for goods delivered on a timely basis, or at all. Any increase in the amount or deterioration in the collectability of accounts receivable will adversely affect our cash flows and results of operations, requiring an increased level of working capital.
17 |
Geographic Concentration
Our operations are primarily split between two geographic areas: North America and Asia.
For the three months ended December 31, 2021, net revenues attributable to our operations in North America totaled $817,341 compared to $406,488 of net revenues attributable to our operations in North America for the three months ended December 31, 2020. Additionally, as of December 31, 2021, $462,389 of our property and equipment, net was attributable to our North American operations, compared to $517,966 attributable to our North American operations as of September 30, 2021.
For the three months ended December 31, 2021, net revenues attributable to our operations in Asia totaled $201,912 compared to $111,499 of net revenues attributable to our operations in Asia during the three months ended December 31, 2020. Additionally, as of December 31, 2021, $177,933 of our property and equipment, net was attributable to our Asian operations, compared to $156,058 attributable to our Asian operations as of September 30, 2021.
Results of Operations
Comparison of three months ended December 31, 2021 and 2020:
Revenue
Three months ended December 31, | Change | |||||||||||||||
2021 | 2020 | Dollars | % | |||||||||||||
Revenue | $ | 1,019,253 | $ | 517,987 | $ | 501,266 | 97 | % |
For the three months ended December 31, 2021, our revenue increased by $501,266, or approximately 97%, compared with the three months ended December 31, 2020. This increase was primarily related to increased co-packing revenue to existing and new customers. In the third and fourth quarters of fiscal year 2021, we expanded our U.S. sales and support operations, which resulted in increased orders and increased co-packing opportunities in the three months ended December 31, 2021.
Cost of sales and gross margin
Three months ended | ||||||||||||||||
December 31, | Change | |||||||||||||||
2021 | 2020 | Dollars | % | |||||||||||||
Cost of sales | $ | 1,003,882 | $ | 516,284 | $ | 487,598 | 94 | % | ||||||||
Gross profit | 15,371 | $ | 1,703 | $ | 13,668 | 803 | % | |||||||||
Gross profit % | 2 | % | 0 | % |
For the three months ended December 31, 2021, we generated a total gross profit of $15,371, from sales of our products and co-packing services, compared to a total gross profit of $1,703 for the three months ended December 31, 2020. The gross margin rate was 2% for the three months ended December 31, 2021, and 0% for the three months ended December 30, 2020. This increase in gross profit was driven primarily by greater scale in our manufacturing operations due to increased production during the current quarter versus the same period in the prior year, combined with increased sales offset by increased materials and labor costs.
18 |
Operating Expenses
Three months ended | ||||||||||||||||
December 31, | Change | |||||||||||||||
2021 | 2020 | Dollars | % | |||||||||||||
Operating Expenses | $ | 2,852,793 | $ | 5,903,826 | $ | (3,051,033 | ) | (52 | )% |
For the three months ended December 31, 2021, the Company’s operating expenses totaled $2,852,793 compared to $5,903,826 for the three months ended December 31, 2020, representing a 52% decrease. This decrease is primarily attributable to a decrease in stock-based compensation expense, offset by an increase in operating expenses associated with greater staffing levels and marketing activities.
Net Loss
Three months ended | ||||||||||||||||
December 31, | Change | |||||||||||||||
2021 | 2020 | Dollars | % | |||||||||||||
Net Loss | $ | 2,804,203 | $ | 5,896,072 | $ | (3,091,869 | ) | (52 | )% |
For the three months ended December 31, 2021, we generated a net loss of $2,804,203 versus $5,896,072 for the three months ended December 31, 2020. This decrease in net loss is primarily attributable to increased revenues and lower stock compensation expense, offset by an increase in operating expenses associated with greater staffing levels and marketing activities.
Liquidity and Capital Resources
Since our inception in 2011, we have incurred significant losses, and as of December 31, 2021, we had an accumulated deficit of approximately $55.6 million. We have not yet achieved profitability and anticipate that we will continue to incur significant sales and marketing expenses prior to recording sufficient revenue from our operations to offset these expenses. In the United States, we expect to incur additional losses because of the costs associated with operating as an exchange-listed public company. We are unable to predict the extent of any future losses or when we will become profitable, if at all.
To date, we have funded our operations primarily with proceeds from registered public offerings and private placements of shares of our common stock. Our principal use of cash is to fund our operations, which includes the commercialization of our single serve coffee products, the continuation of efforts to improve our products, administrative support of our operations and other working capital requirements.
As of December 31, 2021, we had a cash balance of $10,967,104. We believe that our cash and cash equivalents will be sufficient to fund our planned operations and capital expenditure requirements for at least 12 months from February 4, 2022. This evaluation is based on relevant conditions and events that are currently known or reasonably knowable. As a result, we could deplete our available capital resources sooner than we currently expect, and a reduction in consumer demand for, or revenues from the sale of, our single serve coffee products could further constrain our cash resources. We have based these estimates on assumptions that may prove to be wrong, and our operating projections, including our projected revenues from sales of our single serve coffee products, may change as a result of many factors currently unknown to us.
On December 28, 2021, we entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with Maxim Group LLC (“Maxim”), as agent (the “Agent”), pursuant to which we may offer and sell, from time to time, shares of our common stock through the Agent in “at-the-market-offerings”, as defined in Rule 415 under the Securities Act, having an aggregate offering price of up to $20,000,000, subject to any applicable limits when using Form S-3 (the “ATM Offering”). During the period from January 1, 2022 through February 4, 2022, we issued and sold 4,860 shares of our common stock under the Equity Distribution Agreement, raising net proceeds of $12,542.
19 |
In the future, we may seek to raise additional capital through sales of our common stock under the Equity Distribution Agreement. We also expect to receive additional funds upon the exercise for cash of outstanding warrants, if and when exercised at the election of the warrant holders, including the Series A warrants (the “Series A Warrants”) and Series B warrants (the “Series B Warrants” and, collectively with the Series A Warrants, the “Warrants”) that were sold by us in March 2021 in an underwritten registered public offering. For additional information regarding the Warrants, including net proceeds received upon exercise of Warrants in the quarter ended December 31, 2021, see “—Summary of Cash Flows—Financing Activities” and Note 5—Stock Options and Warrants to the Unaudited Consolidated Financial Statements.
In the long-term, we may need to raise additional funds to support our operating activities, and such funding may not be available to us on acceptable terms, or at all. Our need to raise funds will depend on a number of factors, including our ability to generate a sufficient amount of revenues from the sale of our single serve coffee products to fund our business operations, the timing and amount of proceeds from sales of our common stock under the Equity Distribution Agreement, and the timing and amount of funds received upon the exercise for cash of outstanding warrants by the warrant holders. If we are unable to raise additional funds when needed, our operations and ability to execute our business strategy could be adversely affected. Until we can generate a sufficient amount of revenue, we may seek to raise additional funds through equity, equity-linked or debt financings. If we raise additional funds through the incurrence of indebtedness, such indebtedness would have rights that are senior to holders of our equity securities and could contain covenants that restrict our operations. Any additional equity financing may be dilutive to our stockholders.
Our significant contractual cash requirements as of December 31, 2021 primarily include payments for operating and finance lease liabilities and principal and interest on loans. Additionally, we may incur purchase obligations in the ordinary course of business that are enforceable and legally binding and enter into enforceable agreements to purchase goods or services that specify all significant terms, including fixed or minimum quantities to be purchased and fixed or estimated prices to be paid at the time of settlement. As of December 31, 2021, we had payments for lease and loan obligations of approximately $668,933, of which $265,437 are payable within 12 months as of December 31, 2021. We had no purchase obligations as of December 31, 2021.
Summary of Cash Flows
Three Months Ended | ||||||||
December 31, | ||||||||
2021 | 2020 | |||||||
Cash used in operating activities | $ | (1,579,731 | ) | $ | (1,699,073 | ) | ||
Cash used in investing activities | $ | (3,009 | ) | $ | (58,990 | ) | ||
Cash provided by financing activities | $ | 1,701,202 | $ | 2,679,420 | ||||
Effect of foreign exchange on cash | $ | 32,688 | $ | 1,656 | ||||
Net increase in cash | $ | 151,150 | $ | 923,013 |
Operating Activities
We used $1,579,731 and $1,699,073 of cash in operating activities during the three months ended December 31, 2021 and 2020, respectively, principally to fund our operating losses.
Investing Activities
We used $3,009 and $58,990 of cash in investing activities during the three months ended December 31, 2021 and 2020, respectively. Cash used in both periods was to fund the purchase of equipment.
Financing Activities
Historically, we have funded our operations primarily through the issuance of our common stock.
Cash provided by financing activities of $1,701,202 and $2,679,420 for the three months ended December 31, 2021 and 2020, respectively, is primarily related to proceeds received upon the exercise of outstanding Warrants by the Warrant holders in the three months ended December 31, 2021, as further described below, and issuance of equity securities in the three months ended December 31, 2020.
20 |
In the three months ended December 31, 2021, we issued 384,447 shares of common stock related to exercises of warrants, including 380,447 shares of common stock issued upon exercise of 380,447 Series A Warrants and 4,000 shares of common stock issued upon exercise of 8,000 Series B Warrants. In connection with such exercises, in the three months ended December 31, 2021, we received aggregate net proceeds of $1,721,018. For additional information regarding the Series A Warrants and Series B Warrants, see Note 5—Stock Options and Warrants to the Unaudited Consolidated Financial Statements.
ATM Offering
On December 28, 2021, we entered into the Equity Distribution Agreement with Maxim, as Agent, pursuant to which we may offer and sell, from time to time, shares of our common stock through the Agent in “at-the-market-offerings”, as defined in Rule 415 under the Securities Act, having an aggregate offering price of up to $20,000,000, subject to any applicable limits when using Form S-3. The offer and sale of shares will be made pursuant to a shelf registration statement on Form S-3 and the related prospectus (File No. 333-248531) initially filed by us with the SEC on September 1, 2020, and declared effective by the SEC on October 2, 2020, under the Securities Act. We are not obligated to make any sales of shares of our common stock under the Equity Distribution Agreement. As of December 31, 2021, no sales had occurred under the Equity Distribution Agreement. During the period from January 1, 2022 through February 4, 2022, we issued and sold 4,860 shares of our common stock under the Equity Distribution Agreement, raising net proceeds of $12,542.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our financial statements that have been
prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The preparation
of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. US GAAP provides the framework
from which to make these estimates, assumption and disclosures. We choose accounting policies within US GAAP that management believes
are appropriate to accurately and fairly report our operating results and financial position in a consistent manner. Management regularly
assesses these policies in light of current and forecasted economic conditions. See Note 1—Basis of Presentation and Summary of
Significant Accounting Policies of the Notes to the Unaudited Consolidated Financial Statements for a summary of our accounting policies.
There were no significant and material changes in our critical accounting policies and use of estimates during the three months ended December 31, 2021, as compared to those disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, filed with the SEC on December 22, 2021.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.
Item 4. Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our periodic reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is collected and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer are responsible for establishing and maintaining disclosure controls and procedures for our Company. In designing and evaluating our disclosure controls and procedures, management recognizes that no matter how well conceived and operated, disclosure controls and procedures can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our “disclosure controls and procedures” (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q (the “Evaluation Date”). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported, within the time periods specified in the SEC rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
21 |
PART II.
Item 1. Legal Proceedings
On November 23, 2021, Next Vision, Inc. (the “Consultant”) filed a complaint against the Company in the Superior Court of California, County of San Diego Central Division (Case No. 37-2021-00049557-CU-BC-CTL) (the “Complaint”). The Complaint alleges that the Company’s delay in issuing shares of the Company’s common stock (the “Shares”) to the Consultant after receiving due notice from the Consultant of its intent to exercise vested stock options to acquire 70,000 Shares, as initially granted in 2018 (or, as adjusted to account for the Company’s reverse stock split effected on November 12, 2019, vested stock options to acquire 23,334 Shares) (the “Options”), which had previously been issued to the Consultant as compensation for consulting services provided in 2018, breached express and implied contractual obligations to the Consultant and resulted in the Company reporting an overstated amount of income on the IRS Form 1099-B that was issued to the Consultant for U.S. federal tax purposes. In addition, the Complaint alleges that the 23,334 Shares issued to the Consultant upon exercise of the Options improperly contained a six-month restriction on resale and that such restriction prevented the Consultant from selling the Shares at the desired time. The Complaint seeks equitable relief requiring the Company to issue an IRS Form 1099-NEC to reflect the correct amount of compensation. The Complaint also seeks compensatory damages, including to recover for alleged lost profits due to the alleged improper six-month restriction on resale for the Shares, as well as punitive damages, costs of suit, attorney’s fees, and interest. On January 20, 2022, the Company filed its general denial and answer in which it raised affirmative defenses and disputed the claims contained in the Complaint.
We believe the allegations set forth in the Complaint are without merit and intend to defend vigorously against the allegations. However, the Company is not able to predict the outcome, and there is no assurance that the Company will be successful in its defense.
From time to time, we may be subject to other legal proceedings and claims in the ordinary course of business. The results of any future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.
Item 1A. Risk Factors
Except as set forth below, there have been no material changes to our risk factors from those disclosed in our Annual Report on Form 10-K filed with the SEC on December 22, 2021.
A significant portion of our total outstanding shares of common stock are eligible to be sold into the market in the near future, including pursuant to Rule 144, which could cause the market price of our common stock to drop significantly, even if our business is doing well.
Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. We have also registered all shares of common stock that are reserved for issuance under the NuZee, Inc. 2019 Stock Incentive Plan and all shares of common stock currently reserved for issuance under the NuZee, Inc. 2013 Stock Incentive Plan. As a result, these shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates and the lock-up agreements described in our filings with the SEC. A sale under Rule 144 or under any other exemption from the Securities Act, if available, or pursuant to subsequent registrations of our shares of common stock, may have a depressive effect upon the price of our shares of common stock in any active market that may develop. We believe that a significant portion of our total outstanding shares of common stock may be sold in the public market without restriction by non-affiliates pursuant to Rule 144.
We have also entered into the Equity Distribution Agreement with Maxim, as Agent, pursuant to which we may offer and sell, from time to time, shares of our common stock through the Agent in “at-the-market-offerings”, as defined in Rule 415 under the Securities Act, having an aggregate offering price of up to $20,000,000, subject to any applicable limits when using Form S-3. Sales of a substantial number of shares of common stock under the Equity Distribution Agreement, or the perception that those sales may occur, could cause the market price of our common stock to decline.
22 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 6. Exhibits
† Indicates management contract or compensatory plan.
* Filed herewith.
** Furnished herewith.
*** The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.
23 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Date: | February 11, 2022 | NUZEE, INC. | ||
By: | /s/ Masateru Higashida | |||
Masateru Higashida, Chief Executive Officer and President (Principal Executive Officer), Secretary, Treasurer, and Director | ||||
By: | /s/ Patrick Shearer | |||
Patrick Shearer, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
24 |